PRO95780

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PRO95780, covering 2017-05-18 to 2017-06-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of PRO95780 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma That Has Progressed Following Previous Rituximab Therapy (APM4083g) [Phase 2]

See pricing